Autopsy report · NCT01268644

Effects of Metreleptin in Type 1 Diabetes Mellitus

“Sponsor request”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 3 years 11 months before it stopped.
• 8 participants enrolled.
• Results were posted on the registry 5 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Texas Southwestern Medical Center

Sponsor type

University, hospital or other

Conditions

Type 1 Diabetes

Interventions

Leptin

Participants

8

Sites

1

Countries

United States

Trials that died the same way

• A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
  “requested by sponsor” (92% match in meaning)
• A Study to Evaluate ART101 in Adult Participants With Hypertension
  “At Sponsor's Request” (86% match in meaning)
• OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
  “Due to sponsor request” (86% match in meaning)
• Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed
  “Sponsor related” (81% match in meaning)
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
  “Sponsor Decision” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.